FDA Warns of Rare Sleeping Pill Side Effects

Mike Simon
Mike Simon
Contributor
Posted by Mike SimonApril 06, 2007 10:53 AM

The Food and Drug Administration has issued a warning regarding unusual side effects of prescription sleeping pills. The makers of 13 prescription sleeping aids will now be required to put warnings on their labels cautioning that the drug may cause sleep-driving, along with other less dangerous "complex sleep-related behaviors" - like making phone calls, fixing and eating food, and having sex while still asleep.

In short, the FDA advises that people taking the drugs may get up in the middle of the night and drive, or engage in other behavior and have no memory of doing so.

The more dangerous side effects like sleep driving are rare, but the FDA is requiring the warning because of the obvious danger involved, and because there are precautions patients can take to avoid the problem. To lower the risk, patients should never take a prescription sleep aid with alcohol or any other sedating drug, or take a dosage higher than is recommended.

The drugs affected by the FDA's warning are: Ambien; Butisol sodium; Carbrital; Dalmane; Doral; Halcion; Lunesta; Placidyl; Prosom; Restoril; Rozerem; Seconal; and Sonata.


0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard West Virginia

InjuryBoard West Virginia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address